| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |